A small, local pharmaceutical manufacturer was running a clinical trial to assess their Pulmonary Arterial Hypertension product. Just after patient enrollment, their existing drug supplier notified them that they could not access the comparator they needed to conduct their trial. Given that the patients were in the enrollment process, and the sites had already been initiated and trained, the sponsor was in dire need of access to the comparator product.  In a last-ditch effort to save the clinical trial and try to stick to the timelines as best they could, they reached out to WEP Clinical.


WEP Clinical first attempted to work directly with the manufacturer of the comparator drug. However, the manufacturer was not willing to supply the product, as it assumed it was being used to in a clinical trial for a competitor drug. The next approach was to reach out to our extensive network of approved suppliers in the US and Canada.  Through these suppliers, we were able to access enough product to get our customer through their short-term enrollment challenges. Furthermore, because WEP Clinical had multiple suppliers to source from, we were able to get the entire quantity and in a very short period of time. This allowed us to supply enough product for the full clinical trial, despite there being limited supply, due to restrictions from the manufacturer.